Olympus Corporation (Olympus), a global MedTech company committed to advancing endoscopy-enabled care, announced today it has ...
AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality ...
ARACOG trial data highlight cognitive effects of ARPIs in prostate cancer, showing less cognitive decline with darolutamide than enzalutamide, notes Alicia Morgans, MD, MPH. Darolutamide is associated ...
Olympus has signed a definitive agreement to acquire BioProtect for $270 million, adding biodegradable balloon spacer ...
Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announces the launch of the Prolaris + AI Test at the end of this month. Prolaris will be the ...
TOKYO- Olympus is expanding its cancer care portfolio with the acquisition of a medtech company based in Israel. Olympus is ...
A takeover in the US could give investors a better handle on the value of Telix Pharmaceuticals Ltd (ASX: TLX) shares, ...
Learn more about whether Clover Health Investments, Corp. or RadNet, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
CHF 26.4 million (EUR 28.4 million) extension, led by existing investors, accelerates clinical development of NU101 and NU201 radiotheranostic ...
Japanese medical device company Olympus Corporation announced today it has signed a definitive agreement to acquire Israeli ...
In the second piece of our investigation on local enhanced services, Harry Hetherington looks at why GPs take on unfunded LES work ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results